In lung cancer, the stage of the disease at the time of diagnosis is a major factor in determining how to treat the cancer, and how long the patient can expect to live. In general, survival is longest for patients with very early-stage disease and shortest for patients with very advanced disease that has spread to several areas of the body. However, some groupings with very different clinical features can have similar prognosis. Staging is based on the results of physical and...
Read moreSource: ADAM Encyclopedia
Although lung cancer accounts for only 15% of all newly-diagnosed cancers in the United States, it is the leading cause of cancer death in U.S. men... Read more »
Source: ADAM Encyclopedia
Investigative AgentsAccording to a 2001 article, of the nearly 500 cancer drugs in development, 58 (about 13%) were aimed at fighting lung cancer.... Read more »
Source: Medifocus Guidebook on: Non-Small Cell Lung Cancer
The goals of treatment for patients with non-small cell lung cancer include: Remove or shrink the tumor Kill all residual cancer cells Prevent or... Read more »
Source: Medifocus Guidebook on: Non-Small Cell Lung Cancer
In October 2006, the U.S. Food and Drug Administration (FDA) approved the use of bevacizumab (Avastin) in combination with carboplatin and paclitaxel... Read more »
Source: Medifocus Guidebook on: Non-Small Cell Lung Cancer
The lungs are a vital part of the respiratory system that enable oxygen from the air to be taken into the body (inhalation) while also enabling the... Read more »